Amalgamated Bank’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,959
Closed -$8K 3144
2024
Q1
$8K Sell
2,959
-4,697
-61% -$11.5K ﹤0.01% 2553
2023
Q4
$16K Sell
7,656
-881
-10% -$1.61K ﹤0.01% 2756
2023
Q3
$15K Hold
8,537
﹤0.01% 2796
2023
Q2
$17K Buy
+8,537
New +$20K ﹤0.01% 2826
2022
Q2
Sell
-5,144
Closed -$21K 3242
2022
Q1
$21K Buy
+5,144
New +$27.3K ﹤0.01% 2803

Other funds holding GRTS

Amalgamated Bank's GRTS Position: Q2 2024 in Review

Amalgamated Bank sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 2,959 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in GRTS in Q1 2022 and held it in 5 quarters. The position peaked at $21K in Q1 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Amalgamated Bank reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 2,959 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $8K.
  • Amalgamated Bank first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Gritstone bio, Inc. Common Stock position peaked at $21K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.